175 related articles for article (PubMed ID: 12180840)
1. Antibody-mediated activation of the classical complement pathway in xenograft rejection.
Roos A; Daha MR
Transpl Immunol; 2002 May; 9(2-4):257-70. PubMed ID: 12180840
[TBL] [Abstract][Full Text] [Related]
2. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway.
Kerr SR; Dalmasso AP; Apasova EV; Chen SS; Kirschfink M; Matas AJ
Transplantation; 1999 Feb; 67(3):360-5. PubMed ID: 10030279
[TBL] [Abstract][Full Text] [Related]
3. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
[TBL] [Abstract][Full Text] [Related]
4. Antibody mediated rejection in pig-to-nonhuman primate xenotransplantation models.
Cozzi E; Severo M; Bosio E; Besenzon F; Ancona E
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Jun; 5(3):233-53. PubMed ID: 15975037
[TBL] [Abstract][Full Text] [Related]
5. A perspective on xenograft rejection and accommodation.
Platt JL
Immunol Rev; 1994 Oct; 141():127-49. PubMed ID: 7868152
[TBL] [Abstract][Full Text] [Related]
6. Current and future prospects for xenotransplantation.
French AJ; Greenstein JL; Loveland BE; Mountford PS
Reprod Fertil Dev; 1998; 10(7-8):683-96. PubMed ID: 10612477
[TBL] [Abstract][Full Text] [Related]
7. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
Dalmasso AP; Platt JL
Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
[TBL] [Abstract][Full Text] [Related]
8. Beyond antibody-mediated rejection: hyperacute lung rejection as a paradigm for dysregulated inflammation.
Nguyen BH; Zwets E; Schroeder C; Pierson RN; Azimzadeh AM
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Jun; 5(3):255-69. PubMed ID: 15975038
[TBL] [Abstract][Full Text] [Related]
9. Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation.
McCurry KR; Parker W; Cotterell AH; Weidner BC; Lin SS; Daniels LJ; Holzknecht ZE; Byrne GW; Diamond LE; Logan JS; Platt JL
Hum Immunol; 1997 Dec; 58(2):91-105. PubMed ID: 9475338
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation.
Oriol R; Ye Y; Koren E; Cooper DK
Transplantation; 1993 Dec; 56(6):1433-42. PubMed ID: 8279016
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of hyperacute xenograft rejection.
Stevens RB; Platt JL
Am J Kidney Dis; 1992 Oct; 20(4):414-21. PubMed ID: 1415213
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation.
Richards AC; Davies HF; McLaughlin ML; Copeman LS; Holmes BJ; Dos Santos Cruz G; Bycroft S; Chavez G; White DJ; Schuurman HJ; Cozzi E
Transplantation; 2002 Mar; 73(6):881-9. PubMed ID: 11923687
[TBL] [Abstract][Full Text] [Related]
13. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.
Miyatake T; Sato K; Takigami K; Koyamada N; Hancock WW; Bazin H; Latinne D; Bach FH; Soares MP
J Immunol; 1998 Apr; 160(8):4114-23. PubMed ID: 9558123
[TBL] [Abstract][Full Text] [Related]
14. Prevention of hyperacute rejection of pig-to-monkey cardiac xenografts by Chinese cobra venom factor.
Chen G; Wang XM; Sun QY; Shen SQ; Guo H; Wang H; Chen LJ; Wu Y; Wang WY; Xiong YL; Wei QX; Chen S
Transplant Proc; 2001; 33(7-8):3857-8. PubMed ID: 11750642
[No Abstract] [Full Text] [Related]
15. Xenotransplantation: recent progress and current perspectives.
Platt JL
Curr Opin Immunol; 1996 Oct; 8(5):721-8. PubMed ID: 8902399
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts.
Davis EA; Pruitt SK; Greene PS; Ibrahim S; Lam TT; Levin JL; Baldwin WM; Sanfilippo F
Transplantation; 1996 Oct; 62(7):1018-23. PubMed ID: 8878398
[TBL] [Abstract][Full Text] [Related]
17. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model.
Wang H; Rollins SA; Gao Z; Garcia B; Zhang Z; Xing J; Li L; Kellersmann R; Matis LA; Zhong R
Transplantation; 1999 Dec; 68(11):1643-51. PubMed ID: 10609940
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated xenograft injury: mechanisms and protective strategies.
Pierson RN
Transpl Immunol; 2009 Jun; 21(2):65-9. PubMed ID: 19376229
[TBL] [Abstract][Full Text] [Related]
19. Intervention strategies and agents mediating the prevention of xenorejection.
Ghebremariam YT; Smith SA; Anderson JB; Kahn D; Kotwal GJ
Ann N Y Acad Sci; 2005 Nov; 1056():123-43. PubMed ID: 16387682
[TBL] [Abstract][Full Text] [Related]
20. Xenotransplantation: where are we in 2008?
Sprangers B; Waer M; Billiau AD
Kidney Int; 2008 Jul; 74(1):14-21. PubMed ID: 18418354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
